ラパマイシンは、DNA損傷に対する抵抗力を高めることにより、老化するヒト免疫系におけるその老化防止効果を発揮する
Loren Kell1,2,3, Eleanor J Jones4,5, Nima Gharahdaghi4,6
1Department of Biochemistry, University of Oxford, Oxford, UK.
Aging cell
|January 12, 2026
まとめ
mTOR阻害は、ラパマイシンと同様に、DNA損傷を軽減し、細胞生存を改善することにより、ゲノム安定性を直接保護し、健康的な老化と放射線被曝の軽減のための新しい道を提供します。
科学分野:
- 老年学; 分子生物学; 免疫学
背景:
- ラパマイシンのようなmTOR阻害剤は寿命を延ばす特性を示しますが、ヒトにおけるゲノム安定性への影響は不明です。; DNA損傷によって引き起こされる細胞老化は、免疫老化と全体的な生物の老化に寄与します。; mTOR阻害がゲノム安定性にどのように影響するかを理解することは、老化や関連疾患への応用にとって重要です。
主な方法:
- 遺伝毒性ストレスにさらされたヒトT細胞を用いたex vivo研究。; DNA損傷および老化マーカーの老化免疫細胞からの分析。; 高齢者に低用量ラパマイシンを投与するプラセボ対照実験医学研究。
結論:
- mTOR阻害は、その抗老化効果に寄与する新規メカニズムである直接的な遺伝保護を提供します。; mTOR阻害のこの遺伝保護的役割は、寿命を促進する上での有効性を説明する可能性があります。; 低用量mTOR阻害剤は、老化や放射線被曝の懸念を含む、ゲノム不安定性駆動性病理への介入の可能性を表します。
関連する概念動画
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
229
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
229
Replicative Cell Senescence
4.3K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Nucleotide Excision Repair
5.0K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
5.0K
Nucleotide Excision Repair
40.6K
Overview
40.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
218
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
218


